BPC 157 for Acute Hamstring Muscle Strain Repair

Summary

This randomized, double-blind, placebo-controlled Phase 2 study evaluates whether pentadecapeptide BPC 157 (BPC-157), an investigational peptide, can speed structural healing and functional recovery after an acute grade II hamstring muscle strain. Participants will receive BPC 157 or placebo for 14 days in addition to a standardized rehabilitation program. The co-primary endpoints are time to return to unrestricted sport and change in MRI-assessed injury volume at Day 14.

Timeline

Start

2026-02-02

Primary completion

2027-02-14

Completion

2028-02-17

Drugs

Indications